INFORMAZIONI SU QUESTO EPISODIO
Today's episode looks at three research papers: a breast cancer surgery trial about whether women with early-stage lobular carcinoma still need lymph node biopsies, a commentary pushing back on a bone-drug study in postmenopausal Chinese women, and a screening tool analysis that quietly raises questions about who gets flagged for osteoporosis — and who doesn't.
Key Takeaways:
• The SOUND trial showed that many women with early-stage breast cancer can skip sentinel lymph node biopsy, but a new analysis questions whether those findings apply to a specific breast cancer type called invasive lobular carcinoma, which has a higher rate of lymph node involvement than other early-stage cancers.
• Eldecalcitol is a vitamin D analog used for postmenopausal osteoporosis in Japan and studied in Chinese women; a new commentary flags methodological concerns in the supporting study, including the lack of a control group and short follow-up — important caveats before anyone treats this as settled evidence.
• Osteoporosis screening tools developed and validated in one population often underperform in others; a Japanese men's study is a reminder that fracture risk calculators need to be tested — not assumed — in the groups they're used for.
• The gender gap in osteoporosis research runs in both directions: women are underrepresented in cardiovascular trials, but men are often underrepresented in bone health research, which means screening tools calibrated on women may miss at-risk men entirely.
• None of these papers are practice-changing on their own, but each one is the kind of evidence your doctor would weigh when making a specific call — the kind of thing worth knowing so you can ask better questions.
Sources & References:
• Axillary node upstaging in lobular breast cancer — can the SOUND trial results apply? (https://pubmed.ncbi.nlm.nih.gov/42802378/) - PubMed
• Commentary on eldecalcitol and calcium supplementation for postmenopausal osteoporosis in Chinese women (https://pubmed.ncbi.nlm.nih.gov/42802291/) - PubMed
• How well do osteoporosis screening tools work in elderly Japanese men? (https://pubmed.ncbi.nlm.nih.gov/42802288/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-09-28-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
Key Takeaways:
• The SOUND trial showed that many women with early-stage breast cancer can skip sentinel lymph node biopsy, but a new analysis questions whether those findings apply to a specific breast cancer type called invasive lobular carcinoma, which has a higher rate of lymph node involvement than other early-stage cancers.
• Eldecalcitol is a vitamin D analog used for postmenopausal osteoporosis in Japan and studied in Chinese women; a new commentary flags methodological concerns in the supporting study, including the lack of a control group and short follow-up — important caveats before anyone treats this as settled evidence.
• Osteoporosis screening tools developed and validated in one population often underperform in others; a Japanese men's study is a reminder that fracture risk calculators need to be tested — not assumed — in the groups they're used for.
• The gender gap in osteoporosis research runs in both directions: women are underrepresented in cardiovascular trials, but men are often underrepresented in bone health research, which means screening tools calibrated on women may miss at-risk men entirely.
• None of these papers are practice-changing on their own, but each one is the kind of evidence your doctor would weigh when making a specific call — the kind of thing worth knowing so you can ask better questions.
Sources & References:
• Axillary node upstaging in lobular breast cancer — can the SOUND trial results apply? (https://pubmed.ncbi.nlm.nih.gov/42802378/) - PubMed
• Commentary on eldecalcitol and calcium supplementation for postmenopausal osteoporosis in Chinese women (https://pubmed.ncbi.nlm.nih.gov/42802291/) - PubMed
• How well do osteoporosis screening tools work in elderly Japanese men? (https://pubmed.ncbi.nlm.nih.gov/42802288/) - PubMed
Listen with full show notes: https://hotflasher.com/episodes/2026-09-28-research-roundup
Have a menopause story to share? We'd love to hear it:
https://hotflasher.com/share
---
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
Inglese
Stati Uniti
TRASCRIZIONE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di Hot Flasher.
ALTRI EPISODI IN QUESTO PODCAST
ACOG updated its menopause treatment guidelines for the first time since 2014, and several old assumptions didn't survive the revision. This episode also covers a new systematic review on non-hormonal treatments for depression and anxiety during perimenopause and postmenopause, and a strengthened A…
This episode covers three new studies from mid-to-late 2026: what women with PCOS say their experience actually looks like, how your sleep pattern over years — not just last night — connects to heart, kidney, and metabolic disease risk, and what postmenopausal women's diets have to do with their de…
Three new studies land this week with a shared theme the researchers didn't plan: the menopausal transition affects the brain and heart in ways that start earlier, run deeper, and differ more by sex than medicine has historically acknowledged. Nykki breaks down what a vulnerability window before de…
This episode covers three things getting a lot of attention right now: new research on menopause symptoms pushing women out of the workforce, a Cambridge University study on how often women's autoimmune symptoms get dismissed as psychological, and a dermatologist-backed breakdown of what actually w…
Three new studies look at what women are actually eating — and what it's doing to their bones, their vaginal microbiome, and their bladder. Nykki breaks down what the research says and what, if anything, is worth changing this weekend.
Key Takeaways:
• Many women at risk for bone thinning — includ…
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da Hot Flasher, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.